These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 20876699

  • 1. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, van Duijnhoven W, Heeringa M.
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [Abstract] [Full Text] [Related]

  • 2. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M.
    Anesth Analg; 2010 Jan 01; 110(1):74-82. PubMed ID: 19933538
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PA, Smeets JM, Foubert L.
    Br J Anaesth; 2008 Mar 01; 100(3):373-9. PubMed ID: 18238834
    [Abstract] [Full Text] [Related]

  • 4. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I.
    Anesthesiology; 2007 Feb 01; 106(2):283-8. PubMed ID: 17264722
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J, Iwasaki H, Yamakage M, Ozaki M, Kawamata M, Hatano Y, Yorozuya T, Miyakawa H, Kanmura Y.
    Masui; 2014 Oct 01; 63(10):1075-82. PubMed ID: 25693332
    [Abstract] [Full Text] [Related]

  • 6. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ, Woo T, Assaid CA, Lupinacci RJ, Lemmens HJ, Blobner M, Khuenl-Brady KS.
    J Clin Anesth; 2017 Sep 01; 41():84-91. PubMed ID: 28802619
    [Abstract] [Full Text] [Related]

  • 7. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May 01; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 8. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
    Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM.
    Br J Anaesth; 2008 Oct 01; 101(4):492-7. PubMed ID: 18653492
    [Abstract] [Full Text] [Related]

  • 9. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME.
    Anesth Analg; 2007 Mar 01; 104(3):563-8. PubMed ID: 17312209
    [Abstract] [Full Text] [Related]

  • 10. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M, Auer U, West E, Jones RS, Hunter JM.
    Vet J; 2012 Jun 01; 192(3):467-71. PubMed ID: 22030475
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J, Iwasaki H, Otagiri T, Katoh T, Shingu K, Obara H, Nakatsuka H, Tomiyama Y, Kasaba T.
    Masui; 2014 Oct 01; 63(10):1083-8. PubMed ID: 25693333
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
    Zwiers A, van den Heuvel M, Smeets J, Rutherford S.
    Clin Drug Investig; 2011 Oct 01; 31(2):101-11. PubMed ID: 21067251
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM, Duch P, Allingstrup M, Afshari A.
    Cochrane Database Syst Rev; 2017 Aug 14; 8(8):CD012763. PubMed ID: 28806470
    [Abstract] [Full Text] [Related]

  • 14. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 15. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug 07; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 18. Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial.
    Asztalos L, Szabó-Maák Z, Gajdos A, Nemes R, Pongrácz A, Lengyel S, Fülesdi B, Tassonyi E.
    Anesthesiology; 2017 Sep 07; 127(3):441-449. PubMed ID: 28640017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.